Perfluorooctanoate exposure and major birth defects

U.S. Environmental Protection Agency, 2009 U.S. Environmental Protection Agency, 2009 Stahl, 2011, Toxicology of perfluorinated compounds, Environ Sci Eur, 23, 38, 10.1186/2190-4715-23-38 D’Eon, 2011, Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans?, Environ Sci Technol, 45, 7974, 10.1021/es200171y Kato, 2011, Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008, Environ Sci Technol, 45, 8037, 10.1021/es1043613 Jensen, 2012, Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy, Environ Health Perspect, 120, 897, 10.1289/ehp.1104522 Stein, 2011, Comparison of polyfluoroalkyl compound concentrations in maternal serum and amniotic fluid: a pilot study, Reprod Toxicol, 34, 312, 10.1016/j.reprotox.2012.05.039 Inoue, 2004, Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy, Environ Health Perspect, 112, 1204, 10.1289/ehp.6864 Midasch, 2007, Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study, Int Arch Occup Environ Health, 80, 643, 10.1007/s00420-006-0165-9 Monroy, 2008, Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples, Environ Res, 108, 56, 10.1016/j.envres.2008.06.001 Kuklenyik, 2004, Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk, Environ Sci Technol, 38, 3698, 10.1021/es040332u So, 2006, Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China, Environ Sci Technol, 40, 2924, 10.1021/es060031f Tao, 2008, Perfluorinated compounds in human milk from Massachusetts, USA, Environ Sci Technol, 42, 3096, 10.1021/es702789k Tao, 2008, Perfluorinated compounds in human breast milk from several Asian countries, and in infant formula and dairy milk from the United States, Environ Sci Technol, 42, 8597, 10.1021/es801875v Volkel, 2008, Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study, Int J Hyg Environ Health, 211, 440, 10.1016/j.ijheh.2007.07.024 Lau, 2007, Perfluoroalkyl acids: a review of monitoring and toxicological findings, Toxicol Sci, 99, 366, 10.1093/toxsci/kfm128 Lau, 2004, The developmental toxicity of perfluoroalkyl acids and their derivatives, Toxicol Appl Pharmacol, 198, 231, 10.1016/j.taap.2003.11.031 Olsen, 2009, Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives, Reprod Toxicol, 27, 212, 10.1016/j.reprotox.2009.02.001 U.S. Environmental Protection Agency. 2010/2015 PFOA Stewardship Program. Bartell, 2010, Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia, Environ Health Perspect, 118, 222, 10.1289/ehp.0901252 Olsen, 2007, Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers, Environ Health Perspect, 115, 1298, 10.1289/ehp.10009 Thibodeaux, 2003, Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations, Toxicol Sci, 74, 369, 10.1093/toxsci/kfg121 Era, 2009, Cleft palate caused by perfluorooctane sulfonate is caused mainly by extrinsic factors, Toxicology, 256, 42, 10.1016/j.tox.2008.11.003 Jiang, 2012, Perflurooctanoic acid induces developmental cardiotoxicity in chicken embryos and hatchlings, Toxicology, 293, 97, 10.1016/j.tox.2012.01.005 Cheng, 2013, Perfluorooctane sulfonate (PFOS) induced embryotoxicity and disruption of cardiogenesis, Toxicol In vitro: Int J Publ Assoc BIBRA, 27, 1503, 10.1016/j.tiv.2013.03.014 Case, 2001, Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds, Int J Toxicol, 20, 101, 10.1080/10915810151115236 Frisbee, 2009, The C8 health project: design, methods, and participants, Environ Health Perspect, 117, 1873, 10.1289/ehp.0800379 Stein, 2009, Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome, Am J Epidemiol, 170, 837, 10.1093/aje/kwp212 Savitz, 2012, Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community, Epidemiology, 23, 386, 10.1097/EDE.0b013e31824cb93b Nolan, 2010, Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water, Reprod Toxicol, 29, 147, 10.1016/j.reprotox.2009.10.012 Shin, 2011, Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington works facility in West Virginia, Environ Sci Technol, 45, 1435, 10.1021/es102769t Shin, 2011, Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project, Environ Health Perspect, 119, 1760, 10.1289/ehp.1103729 Parker, 2010, Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006, Birth Defects Res A Clin Mol Teratol, 88, 1008, 10.1002/bdra.20735 Lau, 2006, Effects of perfluorooctanoic acid exposure during pregnancy in the mouse, Toxicol Sci, 90, 510, 10.1093/toxsci/kfj105